<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Med (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Med (Lausanne)</journal-id><journal-id journal-id-type="publisher-id">Front. Med.</journal-id><journal-title-group><journal-title>Frontiers in Medicine</journal-title></journal-title-group><issn pub-type="epub">2296-858X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40400631</article-id><article-id pub-id-type="pmc">PMC12092445</article-id><article-id pub-id-type="doi">10.3389/fmed.2025.1551600</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine</subject><subj-group><subject>Case Report</subject></subj-group></subj-group></article-categories><title-group><article-title>Case Report: Pulmonary and gastrointestinal involvement in a rare case of Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia in French Guiana</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Aissaoui</surname><given-names>Houari</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/1283922/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Gaudard</surname><given-names>Dana</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Hadj Amara</surname><given-names>Ghazi</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Aboikoni</surname><given-names>Alolia</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Lingibe</surname><given-names>Yanna</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Louvel</surname><given-names>Dominique</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Medicine B, Cayenne Hospital Center - Andr&#x000e9;e Rosemon</institution>, <addr-line>Cayenne</addr-line>, <country>France</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Internal Medicine, Cayenne Hospital Centre</institution>, <addr-line>Cayenne</addr-line>, <country>France</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Pathology, Cayenne Hospital Centre</institution>, <addr-line>Cayenne</addr-line>, <country>France</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Roberto Giovanni Carbone, University of Genoa, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Antonio Giovanni Solimando, University of Bari Aldo Moro, Italy</p><p>Jindriska Lindsay, University College London, United Kingdom</p></fn><corresp id="c001">*Correspondence: Houari Aissaoui, <email>houari.aissaoui@ch-cayenne.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>12</volume><elocation-id>1551600</elocation-id><history><date date-type="received"><day>26</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Aissaoui, Gaudard, Hadj Amara, Aboikoni, Lingibe and Louvel.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Aissaoui, Gaudard, Hadj Amara, Aboikoni, Lingibe and Louvel</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Background</title><p>Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia (WM) is a rare lymphoproliferative disorder characterized by the proliferation of lymphoplasmacytic cells producing monoclonal immunoglobulin M (IgM). Extra-hematopoietic involvement, although rare, can affect the gastrointestinal tract in approximately 4% of cases and the lungs in 3&#x02013;5% of cases. This case highlights the diversity of extramedullary manifestations in WM and underscores the importance of performing pulmonary and gastrointestinal endoscopies with systematic biopsies for optimal disease management.</p></sec><sec><title>Case presentation</title><p>We report the case of a 60-year-old Haitian man diagnosed with WM in January 2023 following an episode of acute respiratory failure. Biopsies revealed lymphoplasmacytic infiltration in both the bronchial and gastrointestinal mucosa. Biopsies revealed lymphoplasmacytic infiltration in both the bronchial and gastrointestinal mucosa, despite normal macroscopic findings during gastrointestinal endoscopy.</p></sec><sec><title>Conclusion</title><p>This case emphasizes the importance of systematic biopsies during endoscopic examinations, even in the absence of visible lesions, to detect lymphoplasmacytic infiltration in WM. These findings could help in changing the approach to disease management and improving patient outcomes.</p></sec></abstract><kwd-group><kwd>Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia</kwd><kwd>pulmonary and digestive endoscopy</kwd><kwd>extra-hematopoietic involvement</kwd><kwd>lymphoplasmacytic infiltration</kwd><kwd>systematic biopsies</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that no financial support was received for the research and/or publication of this article.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="0"/><equation-count count="0"/><ref-count count="18"/><page-count count="6"/><word-count count="2420"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Pulmonary Medicine</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p>Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia (WM) is a rare form of non-Hodgkin lymphoma characterized by the excessive production of monoclonal immunoglobulin M (IgM) due to lymphoplasmacytic tumor infiltration (<xref rid="B1" ref-type="bibr">1</xref>). First described by Waldenstr&#x000f6;m in 1944 in two male patients (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). The annual incidence in France is 1,300 cases with male predominance (sex ratio: 2.1) and the median age of diagnosis is 73 years (<xref rid="B4" ref-type="bibr">4</xref>). The clinical and hematologic manifestations of WM are well-documented, reflecting both the monoclonal activity of IgM and tissue tumor infiltration (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Bone marrow infiltration occurs in nearly 100% of cases, as reported by Kapoor et al. while extra bone marrow infiltrations are less common, with gastrointestinal involvement in about 4% of cases (<xref rid="B7" ref-type="bibr">7</xref>), pulmonary involvement in 3%&#x02013;5% (<xref rid="B1" ref-type="bibr">1</xref>). The endobronchial involvement is particularly rare.</p><p>Our patient presents a distinct case of Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia with pulmonary parenchymal involvement, lymphoplasmacytic infiltration of the bronchial mucosa with a distinctive petechial endoscopic appearance, and lymphoplasmacytic infiltration of the digestive mucosa, despite a normal gastrointestinal endoscopic appearance. In French Guiana, lymphoproliferative diseases are rarely reported, making this case valuable addition to the local medical literature.</p></sec><sec id="S2"><title>Case report</title><p>We report the case of a 60-year-old Haitian man diagnosed with Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia in January 2023, following an episode of acute respiratory failure requiring a 10-days stay in the intensive care unit. The patient was treated for secondary bacterial infection following H1N1 influenza viral pneumonia, and a hyper viscosity syndrome, which improved gradually with plasma exchange therapy.</p><p>The patient&#x02019;s bone marrow aspirate revealed a polymorphic lymphoid infiltration, including lymphocytes (58%), lymphoplasmacytic cells and plasma cells (10%). Serum protein electrophoresis and immunofixation demonstrated a monoclonal immunoglobulin M of both kappa and lambda types, with a peak concentration of 45.8 g/L. The MYD88 mutation was not detected.</p><p>Thoraco-abdominal-pelvic CT imaging showed multiple areas of parenchymal consolidation with ground-glass opacities (involving 50% of the left lung and 70% of the right lung). Following a multidisciplinary team (MDT) discussion, the patient received six cycles of chemotherapy with Cyclophosphamide and Rituximab from February 15, 2023 to July 18, 2023 in the onco-hematology department. At the end of the treatment, the patient discontinued follow-up.</p><p>In October 2023, the patient experienced a clinical recurrence, presenting with dyspnea, hemoptysis, purulent sputum, and general decline. He was admitted to the pulmonary unit, where vital signs indicated an oxygen desaturation of 92% and fever of 38.4&#x000b0;C. Laboratory findings showed an inflammatory syndrome with leukocytosis of 14,000 G/L, C-Reactive Protein (CRP) of 380 mg/L, microcytic anemia with hemoglobin at 8.8 g/dL, iron deficiency with transferrin saturation at 2%, serum iron at 7.5 &#x003bc;mol/L, Ferritin at 20 ng/mL, a platelets at 190 G/L, prothrombin time (PT) at 81%, and a total protein level of 111 g/L. Hepatic function was normal, and vitamins B9 and B12 were within normal limits.</p><p>Chest scan revealed parenchymal consolidations in both lung fields, predominantly in the left lung (<xref rid="F1" ref-type="fig">Figure 1</xref>), with mediastinal and sub-diaphragmatic infiltration, and minimal right-sided pleural effusion.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Chest CT scan showing chronic pulmonary consolidation in the left lower lobe.</p></caption><graphic xlink:href="fmed-12-1551600-g001" position="float"/></fig><p>Initial empiric antibiotic therapy with Rovamycine and Cefotaxime was administrated for 7 days, resulting in clinical and biological improvement, with CRP decreasing to 9 mg/dL.</p><p>Bronchoscopy revealed a diffuse petechial appearance of the tracheobronchial mucosa (<xref rid="F2" ref-type="fig">Figure 2</xref>). Bronchoalveolar lavage (BAL) fluid analysis showed a cellularity of 450,000 cells/mL, comprising 38% macrophages, 56% lymphocytes, 6% neutrophils, and rare eosinophils. Predominant plasma cells were observed, some of which were atypical and expressed CD45 and CD20, consistent with bronchoalveolar involvement by Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia.</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Bronchoscopic appearance with diffuse petechial involvement of the tracheobronchial mucosa.</p></caption><graphic xlink:href="fmed-12-1551600-g002" position="float"/></fig><p>Staged bronchial biopsies of the spurs revealed massive infiltration by a monomorphic B-cell proliferation (CD20, CD79), with some plasma cells (CD138, IgM) infiltrating mucous-secreting bronchial acini (<xref rid="F4" ref-type="fig">Figure 4</xref>).</p><p>To investigate the iron-deficiency anemia, an upper gastrointestinal endoscopy and rectoscopy were performed. No macroscopic lesions were observed (<xref rid="F3" ref-type="fig">Figure 3</xref>). However, histological analysis of digestive biopsies revealed diffuse lymphoplasmacytic infiltration in the gastric antrum and rectal mucosa (<xref rid="F4" ref-type="fig">Figure 4</xref>).</p><fig position="float" id="F3"><label>FIGURE 3</label><caption><p>Gastrointestinal endoscopy and rectoscopy visualizing the absence of macroscopic lesion of the digestive mucosa.</p></caption><graphic xlink:href="fmed-12-1551600-g003" position="float"/></fig><fig position="float" id="F4"><label>FIGURE 4</label><caption><p>Histological finding from bronchial and digestive biopsy specimens. <bold>(a)</bold> Lymphoplasmacytic cell infiltration in the bronchial chorion, HES (Haematein-Eosin-Saffron), (&#x000d7;10). <bold>(b,c)</bold> CD20+ and IgM+ lymphoplasmacytic cells shown by immunohistochemistry (&#x000d7;20). <bold>(d)</bold> Lymphoplasmacytic cell infiltration in the fundic chorion, HES (Haematein-Eosin-Saffron), (&#x000d7;10). <bold>(e,f)</bold> CD20+ and IgM+ lymphoplasmacytic cells shown by immunohistochemistry (&#x000d7;20).</p></caption><graphic xlink:href="fmed-12-1551600-g004" position="float"/></fig><p>The patient was subsequently referred to the onco-hematology department for a new MDT discussion, a second line treatment with Ibrutinib (420 mg/day) and plasmapheresis was initiated on January 2024. Unfortunately, the patient passed away in October 2024.</p><p>
<bold>Table showing the timeline of cares:</bold>
</p><table-wrap position="float" id="T1"><table frame="box" rules="all" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Date</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Event</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Outcome</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Jan 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Diagnosis of WM following acute respiratory failure</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013; Lymphoplasmacytic infiltration in bone marrow + monoclonal IgM.-Chest scan: Parenchymal consolidations.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Feb 2023</td><td valign="top" align="left" rowspan="1" colspan="1">MDT discussion</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013; 6 cycles of Cyclophosphamide and Rituximab.</td></tr><tr><td valign="top" align="left" colspan="3" style="background-color: #dcdcdc;" rowspan="1">
<bold>Discontinuation of medical follow-up</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Oct 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Clinical recurrence with respiratory distress.</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013; Clinical and biological improvement under an antibiotic therapy. -Chest scan: Persistent parenchymal consolidations.-Bronchoscopy: petechial appearance of tracheobronchial mucosa.-Lymphoplasmacytic infiltration of the bronchial mucosa-Lymphoplasmacytic infiltration in gastric antrum and rectal mucosa.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Jan 2024</td><td valign="top" align="left" rowspan="1" colspan="1">New MDT discussion</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013; Switch to Ibrutinib 420 mg/day with plasmapheresis.</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Oct 2024</td><td valign="top" align="left" colspan="2" rowspan="1">
<bold>Patient&#x02019;s death</bold>
</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion" id="S3"><title>Discussion</title><p>Extramedullary infiltrations in Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia (WM) are variable and rarely predominant (<xref rid="B8" ref-type="bibr">8</xref>). Rabiner et al. documented a case of WM without bone marrow infiltration, where pulmonary involvement was the sole manifestation, with dense lymphoproliferative infiltration of the bronchial mucosa evident on biopsy (<xref rid="B9" ref-type="bibr">9</xref>). The first case of pulmonary involvement in WM was described by Noah in 1956 (<xref rid="B10" ref-type="bibr">10</xref>), in a patient with widespread disease including bone marrow involvement. Since then, multiples case reports and reviews have documented a range of non-specific pulmonary manifestations, including parenchymal masses, reticular and nodular infiltrates, pleural effusions, and chylothorax (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>).</p><p>In WM, the onset of respiratory symptoms warrants investigation for possible pulmonary involvement or secondary infection (<xref rid="B13" ref-type="bibr">13</xref>). In our case, despite recurring respiratory infections, chest CT findings were consistent with consolidations described in the literature.</p><p>As a non-Hodgkin lymphoma (NHL), endobronchial airway involvement was described by Rose et al. in 1986 (<xref rid="B14" ref-type="bibr">14</xref>). The authors reported two patterns observed in three cases of NHL and 17 additional cases reviewed from the literature: diffuse submucosal infiltrates (type 1) and a solitary mass in the central airways (type 2). Notably, Waldenstr&#x000f6;m&#x02019;s macroglobulinemia was not among the histologic patterns observed in these cases.</p><p>A literature review yielded three confirmed cases of WM with airway involvement observed during bronchoscopy, reported between 1992 to 2016. Sakai et al. documented multiple submucosal nodules in the trachea with significant lymphoplasmacytic infiltration on biopsy (<xref rid="B15" ref-type="bibr">15</xref>). Fadil and Taylor reported subtotal occlusion of the left upper lobe with diffuse mucosal irregularity (<xref rid="B2" ref-type="bibr">2</xref>). Hana et al. described an obstructive lesion in the right lower lobe with granulations in the trachea, necessitating interventional pulmonology procedures (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>The petechial appearance of the trachea and bronchi in our patient&#x02019;s bronchoscopy likely reflects mucosal bleeding, which can be a feature of WM. This bleeding has been attributed by some authors (<xref rid="B17" ref-type="bibr">17</xref>) to platelet dysfunction or an acquired Von Willebrand factor syndrome, both associated with the blood hyperviscosity seen in approximately 30% of WM cases (<xref rid="B17" ref-type="bibr">17</xref>). Additionally, mucosal bleeding may result from thrombocytopenia due to the tumor bone marrow infiltration.</p><p>Malabsorption syndrome, diarrhea, and gastrointestinal bleeding are frequently indicative of gastrointestinal tract involvement in WM (<xref rid="B1" ref-type="bibr">1</xref>). Our patient presented with iron-deficiency anemia and normal endoscopic findings, resulting from malabsorption secondary to lymphoplasmacytic infiltration of the digestive mucosa.</p><p>We are facing an aggressive form of WM with extra-medullary manifestations, particularly bronchial and gastrointestinal lymphoplasmacytic infiltrations, that progressed despite two lines of treatment, ultimately leading to the patient&#x02019;s death. Recent research has highlighted the role of the immune microenvironment in WM pathogenesis, especially the interaction between WM cells and regulatory T cells via the CD40/CD40-ligand axis (<xref rid="B18" ref-type="bibr">18</xref>). This molecular understanding may lead to new therapeutic approaches.</p></sec><sec sec-type="conclusion" id="S4"><title>Conclusion</title><p>In this case, the simultaneous bronchial and gastrointestinal lymphoplasmacytic infiltrations represent an unusual manifestation of Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia. Although pulmonary infiltration has been documented in several cases, concurrent endobronchial and gastrointestinal involvement is rarely reported.</p><p>This case highlights the importance of both bronchial and digestive endoscopic examinations in managing Waldenstr&#x000f6;m&#x02019;s Macroglobulinemia. Systematic biopsies, even in the absence of visible lesions, may reveal lymphoplasmacytic tumor infiltrations.</p></sec></body><back><ack><p>We thank the patient for providing informed consent for the publication of this case. We also thank the medical teams involved in the patient&#x02019;s care for their collaboration.</p></ack><sec sec-type="data-availability" id="S6"><title>Data availability statement</title><p>The original contributions presented in this study are included in this article/supplementary material, further inquiries can be directed to the corresponding author.</p></sec><sec sec-type="ethics-statement" id="S7"><title>Ethics statement</title><p>Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></sec><sec sec-type="author-contributions" id="S8"><title>Author contributions</title><p>HA: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x02013; original draft, Writing &#x02013; review and editing. DG: Conceptualization, Methodology, Resources, Writing &#x02013; original draft. GH: Conceptualization, Data curation, Resources, Writing &#x02013; review and editing. AA: Conceptualization, Data curation, Investigation, Writing &#x02013; review and editing. YL: Methodology, Resources, Software, Writing &#x02013; original draft. DL: Conceptualization, Data curation, Supervision, Validation, Writing &#x02013; review and editing.</p></sec><sec sec-type="COI-statement" id="S10"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="S11"><title>Generative AI statement</title><p>The authors declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="S12"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez Botero</surname><given-names>N</given-names></name><name><surname>Zerrate Misas</surname><given-names>A</given-names></name><name><surname>Galvez Cardenas</surname><given-names>K</given-names></name><name><surname>Ramirez Quintero</surname><given-names>J</given-names></name></person-group>. <article-title>Chylothorax as an initial manifestation of Waldenstr&#x000f6;m macroglobulinemia.</article-title>
<source><italic>Cureus.</italic></source> (<year>2020</year>) <volume>12</volume>:<fpage>e7566</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.7566</pub-id>
<pub-id pub-id-type="pmid">32382468</pub-id>
</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadil</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>D</given-names></name></person-group>. <article-title>The lung and Waldenstr&#x000f6;m&#x02019;s macroglobulinemia.</article-title>
<source><italic>South Med J.</italic></source> (<year>1998</year>) <volume>91</volume>:<fpage>681</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/00007611-199807000-00017</pub-id>
<pub-id pub-id-type="pmid">9671845</pub-id>
</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldenstr&#x000f6;m</surname><given-names>J</given-names></name></person-group>. <article-title>Incipient myelomatosis or &#x0201c;essential&#x0201d; hyperglobulinemia with fibrinogen peia-&#x0201d;new syndrome&#x0201d;?</article-title>
<source><italic>Acta Med Scandinav.</italic></source> (<year>1944</year>) <volume>117</volume>:<fpage>216</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1111/j.0954-6820.1944.tb03955.x</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouclet</surname><given-names>F</given-names></name><name><surname>Krzisch</surname><given-names>D</given-names></name><name><surname>Leblond</surname><given-names>V</given-names></name><name><surname>Tomowiak</surname><given-names>C</given-names></name><name><surname>Laribi</surname><given-names>K</given-names></name><name><surname>Ysebaert</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>[Waldenstr&#x000f6;m disease: News and perspectives in 2022].</article-title>
<source><italic>Bull Cancer.</italic></source> (<year>2023</year>) <volume>110</volume>:<fpage>88</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.bulcan.2022.08.012</pub-id>
<pub-id pub-id-type="pmid">36229266</pub-id>
</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghobrial</surname><given-names>I</given-names></name><name><surname>Gertz</surname><given-names>M</given-names></name><name><surname>Fonseca</surname><given-names>R</given-names></name></person-group>. <article-title>Waldenstr&#x000f6;m macroglobulinaemia.</article-title>
<source><italic>Lancet Oncol.</italic></source> (<year>2003</year>) <volume>4</volume>:<fpage>679</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/s1470-2045(03)01246-4</pub-id>
<pub-id pub-id-type="pmid">14602248</pub-id>
</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>K</given-names></name><name><surname>Alsina</surname><given-names>M</given-names></name><name><surname>Bensinger</surname><given-names>W</given-names></name><name><surname>Biermann</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Devine</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Waldenstr&#x000f6;m&#x02019;s macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.</article-title>
<source><italic>J Natl Compr Canc Netw.</italic></source> (<year>2012</year>) <volume>10</volume>:<fpage>1211</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.6004/jnccn.2012.0128</pub-id>
<pub-id pub-id-type="pmid">23054875</pub-id>
</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>P</given-names></name><name><surname>Paludo</surname><given-names>J</given-names></name><name><surname>Vallumsetla</surname><given-names>N</given-names></name><name><surname>Greipp</surname><given-names>P</given-names></name></person-group>. <article-title>Waldenstr&#x000f6;m macroglobulinemia: What a hematologist needs to know.</article-title>
<source><italic>Blood Rev.</italic></source> (<year>2015</year>) <volume>29</volume>:<fpage>301</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.blre.2015.03.001</pub-id>
<pub-id pub-id-type="pmid">25882617</pub-id>
</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banwait</surname><given-names>R</given-names></name><name><surname>Aljawai</surname><given-names>Y</given-names></name><name><surname>Cappuccio</surname><given-names>J</given-names></name><name><surname>McDiarmid</surname><given-names>S</given-names></name><name><surname>Morgan</surname><given-names>E</given-names></name><name><surname>Leblebjian</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Extramedullary Waldenstr&#x000f6;m macroglobulinemia.</article-title>
<source><italic>Am J Hematol.</italic></source> (<year>2015</year>) <volume>90</volume>:<fpage>100</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/ajh.23880</pub-id>
<pub-id pub-id-type="pmid">25349134</pub-id>
</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabiner</surname><given-names>S</given-names></name><name><surname>Aprill</surname><given-names>S</given-names></name><name><surname>Radner</surname><given-names>D</given-names></name></person-group>. <article-title>Waldenstr&#x000f6;m&#x02019;s macroglobulinemia. Report of a case with pulmonary involvement and improvement in pulmonary symptoms only following chlorambucil therapy.</article-title>
<source><italic>Am J Med.</italic></source> (<year>1972</year>) <volume>53</volume>:<fpage>685</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9343(72)90163-5</pub-id>
<pub-id pub-id-type="pmid">4628013</pub-id>
</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noach</surname><given-names>A</given-names></name></person-group>. <article-title>[Pulmonary involvement in Waldenstr&#x000f6;m&#x02019;s macroglobulinemia].</article-title>
<source><italic>Ned Tijdschr Geneeskd.</italic></source> (<year>1956</year>) <volume>100</volume>:<fpage>3881</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">13400202</pub-id>
</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname><given-names>C</given-names></name><name><surname>Rabinowitz</surname><given-names>I</given-names></name></person-group>. <article-title>An unusual reoccurrence of Waldenstrom&#x02019;s macroglobulinemia as pleural effusions that had a discordant response with treatment.</article-title>
<source><italic>Clin Lab Haematol.</italic></source> (<year>2005</year>) <volume>27</volume>:<fpage>200</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2257.2005.00666.x</pub-id>
<pub-id pub-id-type="pmid">15938727</pub-id>
</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rausch</surname><given-names>P</given-names></name><name><surname>Herion</surname><given-names>J</given-names></name></person-group>. <article-title>Pulmonary manifestations of Waldenstrom macroglobulinemia.</article-title>
<source><italic>Am J Hematol.</italic></source> (<year>1980</year>) <volume>9</volume>:<fpage>201</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ajh.2830090208</pub-id>
<pub-id pub-id-type="pmid">6776807</pub-id>
</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Yoshii</surname><given-names>Y</given-names></name><name><surname>Taka</surname><given-names>T</given-names></name><name><surname>Min</surname><given-names>K</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name></person-group>. <article-title>Waldenstr&#x000f6;m&#x02019;s macroglobulinemia. Report of an autopsy case presenting with a pulmonary manifestation.</article-title>
<source><italic>Virchows Arch A Pathol Anat Histopathol.</italic></source> (<year>1989</year>) <volume>415</volume>:<fpage>169</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/BF00784355</pub-id>
<pub-id pub-id-type="pmid">2500771</pub-id>
</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>R</given-names></name><name><surname>Grigas</surname><given-names>D</given-names></name><name><surname>Strattemeir</surname><given-names>E</given-names></name><name><surname>Harris</surname><given-names>N</given-names></name><name><surname>Linggood</surname><given-names>R</given-names></name></person-group>. <article-title>Endobronchial involvement with non-Hodgkin&#x02019;s lymphoma. A clinical-radiologic analysis.</article-title>
<source><italic>Cancer.</italic></source> (<year>1986</year>) <volume>57</volume>:<fpage>1750</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/1097-0142(19860501)57:9&#x0003c;1750::aid-cncr2820570907&#x0003e;3.0.co;2-j</pub-id><pub-id pub-id-type="pmid">3955520</pub-id>
</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>I</given-names></name><name><surname>Shiroguchi</surname><given-names>T</given-names></name><name><surname>Kanegae</surname><given-names>H</given-names></name><name><surname>Matumoto</surname><given-names>I</given-names></name></person-group>. <article-title>Endobronchial involvement with Waldenstr&#x000f6;m&#x02019;s macroglobulinemia.</article-title>
<source><italic>Intern Med.</italic></source> (<year>1992</year>) <volume>31</volume>:<fpage>1098</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.2169/internalmedicine.31.1098</pub-id>
<pub-id pub-id-type="pmid">1421716</pub-id>
</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bart&#x000e1;kov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Nov&#x000e1;k</surname><given-names>J</given-names></name><name><surname>Jak&#x00161;a</surname><given-names>R</given-names></name><name><surname>Bene&#x00161;</surname><given-names>J</given-names></name><name><surname>Votruba</surname><given-names>J</given-names></name></person-group>. <article-title>Endobronchial involvement as an extremely rare manifestation of the Waldenstr&#x000f6;m&#x02019;s disease.</article-title>
<source><italic>Clin Respir J.</italic></source> (<year>2018</year>) <volume>12</volume>:<fpage>816</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/crj.12567</pub-id>
<pub-id pub-id-type="pmid">27696747</pub-id>
</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brysland</surname><given-names>S</given-names></name><name><surname>Maqbool</surname><given-names>M</given-names></name><name><surname>Talaulikar</surname><given-names>D</given-names></name><name><surname>Gardiner</surname><given-names>E</given-names></name></person-group>. <article-title>Bleeding Propensity in Waldenstr&#x000f6;m Macroglobulinemia: Potential Causes and Evaluation.</article-title>
<source><italic>Thromb Haemost.</italic></source> (<year>2022</year>) <volume>122</volume>:<fpage>1843</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1055/a-1896-7092</pub-id>
<pub-id pub-id-type="pmid">35817084</pub-id>
</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname><given-names>A</given-names></name><name><surname>Desantis</surname><given-names>V</given-names></name><name><surname>Celay</surname><given-names>J</given-names></name><name><surname>Giustini</surname><given-names>V</given-names></name><name><surname>Rigali</surname><given-names>F</given-names></name><name><surname>Savino</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Targeting the immune microenvironment in Waldenstr&#x000f6;m macroglobulinemia via halting the CD40/CD40-ligand axis.</article-title>
<source><italic>Blood.</italic></source> (<year>2023</year>) <volume>141</volume>:<fpage>2615</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1182/blood.2022019240</pub-id>
<pub-id pub-id-type="pmid">36735903</pub-id>
</mixed-citation></ref></ref-list></back></article>